webinar register page

How COVID-19 is Shaping the Digital Health Space
The COVID-19 pandemic has fundamentally altered health priorities around the world. Across all sectors, organizations are engaging with digital solutions to tackle the spread of the virus and relying on data to make critical decisions around healthcare delivery and resource prioritization. In this webinar, panelists will discuss why we are seeing an increase in the use of digital during the COVID-19 pandemic, and how this extreme experience has awakened the world to the crucial infrastructure that needs to be in place in order to rapidly respond to future health emergencies.

Moderator: Bruno Villetelle
Head of Data and Digital Global Drug Development, Novartis

Bruno joined Novartis in April 2019 and leads the Data and Digital function for the company’s Global Drug Development (GDD) organization. He drives GDD’s data and digital vision, strategy and governance, and is focused on embedding data science and digital technologies to enhance asset development. Bruno has more than 30 years of experience spearheading digital and technology led innovation and new business model creation in the pharmaceutical, consumer health, and service industries. Prior to joining Novartis, he worked for Takeda Pharmaceutical Company Limited as the Chief Digital Officer.

Bruno has a Master of Science degree in Industrial Organization & Methodology and a Master of Science in Business Systems Management from the University of Lyon, France. He also has a Master of Engineering in Enterprise Information Systems from the Conservatoire des Arts et Métiers, France. In 2017, he was nominated one of the Top 40 healthcare transformers by MM&M (Medical, Marketing and Media).

Oct 29, 2020 09:00 AM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Maimuna (Maia) Majumder
Instructor @Boston Children’s Hospital & Harvard Medical School
Dr. Maimuna (Maia) Majumder is a member of the ladder-rank faculty at the Computational Health Informatics Program (CHIP) based out of Harvard Medical School and Boston Children’s Hospital and a recent graduate of the Engineering Systems program at MIT’s Institute for Data, Systems, and Society (IDSS). In between her graduate studies and her current position at CHIP, Maia spent a year at the Health Policy Data Science lab at Harvard Medical School’s Health Care Policy department as a postdoctoral fellow. Her current research interests involve probabilistic modeling, data science, and “systems epidemiology” in the context of public health, with a focus on causal inference for infectious disease surveillance using digital disease data (e.g. search trends; news and social media).
Helmi Zakariah, MD
CEO @Artificial Intelligence in Medical Epidemiology (AIME)
Dr Helmi Zakariah begins his journey in Big Data Analytics & Digital Epidemiology as the Chief Executive Officer of AIME and AI4Good, where he led the delivery of data analytics solutions in public health, women & reproductive health, and sustainable agriculture across 3 continents. In Nov 2019, Dr Helmi Zakariah was appointed as a member of the WHO/ITU Working Group for AI in Outbreak, a multi-institutional and global platform that aims to leverage Machine Learning to mitigate outbreaks. When the Covid19 pandemic reached Malaysia, he was tasked to lead the Digital Epidemiology portfolio for the Selangor State Task Force for Covid19. Dr Helmi Zakariah had his early education in MRSM Jasin, and holds a Medical Degree from the Russian Federation with a Master in International Public Health from the University of Liverpool, United Kingdom. He regularly speaks through global cooperative forums like Chatham House, World Economic Forum, and Commonwealth Digital Health Forum.
Akhona Tshangela
Programme Manager, Mortality Surveillance @Africa Center for Disease Control and Prevention
Ms. Akhona Tshangela joined the Africa CDC in 2016 and as one of its first staff members, she played a critical role in launching Africa CDC and developing its first programs. Currently she manages the Mortality Surveillance Program. In this role, Akhona is responsible for designing and executing the program’s strategy for understanding the numbers and causes of death in African countries, and improving the use of this data for decision making. Currently for the COVID-19 response she is the Chief Science Officer and co-chairs the Sciences, regulations and standards technical working group; under the Africa Task Force on Coronavirus (AFTCOR), a joint partnership between Africa CDC and Member States, supporting Member States with making science based policy decisions. She is also a member of the women in global health movement and is passionate about building gender equity in public health.